LOS ANGELES, Oct. 16, 2024 (GLOBE NEWSWIRE) -- 2X Grammy-nominated producer, DJ, and entrepreneur Steve Aoki has officially ...

Smith+Nephew (LSE: SN, NYSE: SNN), the global medical technology company, is proud to announce that its RENASYS EDGE Negative ...

Behavioral health care services are the first phase of the school-based health clinic. Renovations are underway in the existing space to house primary care services delivered by a local health care ...

BMB-201, a selective 5-HT2A/2C receptor agonist, was designed to harness the analgesic potential of serotonin modulation without the hallucinogenic effects commonly associated with 5-HT2A activation.

On the basis of the completed due diligence, ChemoMetec today submitted a binding tender offer for the acquisition of 100% of the shares of Belgian company Ovizio Imaging Systems SA (’Ovizio’). The ...

SALT LAKE CITY, Oct. 16, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced a strategic partnership with jscreen™, a ...

Based on this, the Company now expects revenue for the 2024/25 financial year in the DKK 445-460 million range, up from DKK 435-450 million in the most recent guidance, and EBITDA in the DKK 222-230 ...

Founder & Chief Executive Officer of FibroBiologics, Pete O’Heeron said, “The issuance of this patent recognizes the novelty and utility of using modified fibroblasts to deliver tumor-inhibiting ...

Under this expanded agreement, Optime Care will now manage commercial distribution for three Rigel products: TAVALISSE, GAVRETO ® (pralsetinib) and Rezlidhia ® (olutasidenib),” says Stephanie ...

IRVING, Texas, Oct. 16, 2024 (GLOBE NEWSWIRE) -- U.S. Oral Surgery Management (USOSM) President and CEO Richard Hall recently received the SCALE Community MSO Excellence Award, which recognizes ...

Cepham emphasizes that while it is committed to addressing women’s health, men’s health remains equally crucial. In the coming months, Cepham will share insights on misconceptions in men’s health ...

Positive data from 876-patient head-to-head trial versus Shingrix ® shows amezosvatein elicits robust humoral and cellular immune responses with comparatively lower reactogeni ...